(Total Views: 241)
Posted On: 07/14/2022 8:04:23 AM
Post# of 3
HERE’S WHY YOU SHOULD KEENLY WATCH GREENWICH LIFESCIENCES
$GLSI
Greenwich LifeSciences, Inc. (NASDAQ: GLSI), a clinical-stage pharmaceutical company, developing immunotherapy to prevent breast cancer recurrence in patients who previously underwent surgery, announced the removal of the clinical hold on the Phase III Flamingo-01 clinical trial by the U.S Food and Drug Administration (FDA).
Here's why you should keenly watch Greenwich LifeSciences!
Read on to know more:
https://www.aviseanalytics.com/heres-why-you-...esciences/
$GLSI
Greenwich LifeSciences, Inc. (NASDAQ: GLSI), a clinical-stage pharmaceutical company, developing immunotherapy to prevent breast cancer recurrence in patients who previously underwent surgery, announced the removal of the clinical hold on the Phase III Flamingo-01 clinical trial by the U.S Food and Drug Administration (FDA).
Here's why you should keenly watch Greenwich LifeSciences!
Read on to know more:
https://www.aviseanalytics.com/heres-why-you-...esciences/
(0)
(0)Scroll down for more posts ▼
